Cargando…

Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives

OBJECTIVES: Clinical guidelines or guidance is an important tool for preventing and treating antimicrobial-resistant (AMR) infections. We sought to understand and support the effective use of guidelines and guidance for AMR infections. METHODS: Key informant interviews and a stakeholder meeting on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, Rhea E., Felt-Lisk, Sue, Chen, Arnold, Sullivan, Casey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972534/
https://www.ncbi.nlm.nih.gov/pubmed/36865700
http://dx.doi.org/10.1017/ash.2022.319
_version_ 1784898345593995264
author Powell, Rhea E.
Felt-Lisk, Sue
Chen, Arnold
Sullivan, Casey
author_facet Powell, Rhea E.
Felt-Lisk, Sue
Chen, Arnold
Sullivan, Casey
author_sort Powell, Rhea E.
collection PubMed
description OBJECTIVES: Clinical guidelines or guidance is an important tool for preventing and treating antimicrobial-resistant (AMR) infections. We sought to understand and support the effective use of guidelines and guidance for AMR infections. METHODS: Key informant interviews and a stakeholder meeting on the development and use of guidelines and guidance for management of AMR infections; the interview findings and meeting discussion informed a conceptual framework for AMR infection clinical guidelines. PARTICIPANTS: Interview participants included experts with experience in guidelines development and physician and pharmacist hospital leaders and antibiotic stewardship program leaders. Stakeholder meeting participants included federal and nonfederal participants involved in research, policy, and practice related to prevention and management of AMR infections. RESULTS: Participants described challenges related to timeliness of guidelines, methodologic limitations of the development process, and issues with usability across a range of clinical settings. These findings, and participants’ suggestions for mitigating the challenges identified, informed a conceptual framework for AMR infection clinical guidelines. The framework components include (1) science and evidence, (2) guideline and guidance development and dissemination, and (3) implementation and real-world practice. These components are supported by engaged stakeholders whose leadership and resources help to improve patient and population AMR infection prevention and management. CONCLUSIONS: Use of guidelines and guidance documents for management of AMR infections can be supported through (1) a robust body of scientific evidence to inform guidelines and guidance; (2) approaches and tools to support timely, transparent guidelines that are relevant and actionable for all clinical audiences; and (3) tools to implement guidelines and guidance effectively.
format Online
Article
Text
id pubmed-9972534
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-99725342023-03-01 Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives Powell, Rhea E. Felt-Lisk, Sue Chen, Arnold Sullivan, Casey Antimicrob Steward Healthc Epidemiol Original Article OBJECTIVES: Clinical guidelines or guidance is an important tool for preventing and treating antimicrobial-resistant (AMR) infections. We sought to understand and support the effective use of guidelines and guidance for AMR infections. METHODS: Key informant interviews and a stakeholder meeting on the development and use of guidelines and guidance for management of AMR infections; the interview findings and meeting discussion informed a conceptual framework for AMR infection clinical guidelines. PARTICIPANTS: Interview participants included experts with experience in guidelines development and physician and pharmacist hospital leaders and antibiotic stewardship program leaders. Stakeholder meeting participants included federal and nonfederal participants involved in research, policy, and practice related to prevention and management of AMR infections. RESULTS: Participants described challenges related to timeliness of guidelines, methodologic limitations of the development process, and issues with usability across a range of clinical settings. These findings, and participants’ suggestions for mitigating the challenges identified, informed a conceptual framework for AMR infection clinical guidelines. The framework components include (1) science and evidence, (2) guideline and guidance development and dissemination, and (3) implementation and real-world practice. These components are supported by engaged stakeholders whose leadership and resources help to improve patient and population AMR infection prevention and management. CONCLUSIONS: Use of guidelines and guidance documents for management of AMR infections can be supported through (1) a robust body of scientific evidence to inform guidelines and guidance; (2) approaches and tools to support timely, transparent guidelines that are relevant and actionable for all clinical audiences; and (3) tools to implement guidelines and guidance effectively. Cambridge University Press 2023-02-16 /pmc/articles/PMC9972534/ /pubmed/36865700 http://dx.doi.org/10.1017/ash.2022.319 Text en © The Author(s) 2023 This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Original Article
Powell, Rhea E.
Felt-Lisk, Sue
Chen, Arnold
Sullivan, Casey
Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives
title Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives
title_full Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives
title_fullStr Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives
title_full_unstemmed Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives
title_short Optimizing clinical guidelines to address antimicrobial-resistant infections: A conceptual framework reflecting stakeholder perspectives
title_sort optimizing clinical guidelines to address antimicrobial-resistant infections: a conceptual framework reflecting stakeholder perspectives
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972534/
https://www.ncbi.nlm.nih.gov/pubmed/36865700
http://dx.doi.org/10.1017/ash.2022.319
work_keys_str_mv AT powellrheae optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives
AT feltlisksue optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives
AT chenarnold optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives
AT sullivancasey optimizingclinicalguidelinestoaddressantimicrobialresistantinfectionsaconceptualframeworkreflectingstakeholderperspectives